Effects of rivastigmine on cognitive function and appetite.
Not Applicable
Recruiting
- Conditions
- Alzheimer's disease
- Registration Number
- JPRN-UMIN000041148
- Lead Sponsor
- Second Department of Internal Medicine, Faculty of Medical Scieces, University of Fukui
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 0
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have any of the following are excluded. 1. Patients who participated in other clinical trials within 4 months 2. Other patients who the investigator determined to be unsuitable for study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Appetite Questionnaire (JSNAQ) (at the start of the test, 3, 6 and 12 months)
- Secondary Outcome Measures
Name Time Method MMSE-J (cognitive function evaluation) (at the start of the test, 3, 6 and 12 months) ADAS-Jcog (cognitive function evaluation) (at the start of the study, 3, 6, and 12 months)